Failure to account for background rates when considering adverse events from pandemic H1N1 flu vaccination could spark public panic, researchers cautioned.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — House Democrats released their healthcare reform bill this week — nearly 2,000 pages of it — along with a new bill to eliminate the sustainable growth rate (SGR) formula and establish a new method to pay doctors under Medicare.
No Comments »
Filed under: General Health News
PHILADELPHIA (MedPage Today) — In this InFocus™ discussion, infectious disease experts Richard Whitley, MD, and Arnold Monto, MD, look at why healthcare workers on the front lines of the H1N1 flu pandemic may not be getting clear messages about how to treat and prevent the virus.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — The U.S. Senate has confirmed Regina Benjamin, MD, MBA, a family physician in an Alabama Gulf Coast shrimping town, as Surgeon General of the United States.
No Comments »
Filed under: General Health News
Bayer HealthCare presented results from a global Phase II study of florbetaben, its imaging agent in development for the detection of cerebral beta-Amyloid plaques, at the 19th World Congress of Neurology (WCN).
No Comments »
Filed under: Pharmacy News
Sunesis Pharmaceuticals, Inc. today reported that it has completed enrollment in the REVEAL-1 (Response Evaluation of VorEloxin in AmL) trial, a Phase 2 dose regimen optimization trial of single agent voreloxin in newly diagnosed elderly acute myeloid leukemia (AML) patients who are unlikely to benefit from standard induction chemotherapy. A total of 113 patients were [...]
No Comments »
Filed under: Pharmacy News
Idenix Pharmaceuticals, Inc.a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced presentations of data on IDX184, a once-daily novel liver-targeted nucleotide prodrug of 2′-methyl guanosine (2′MeG) for the treatment of HCV, at the annual meeting of the American Association for the Study of Liver [...]
No Comments »
Filed under: Pharmacy News
Oncolytics Biotech Inc. announced that a poster presentation covering updated results of a Phase II study of REOLYSIN(R) administered intravenously to patients with sarcomas metastatic to the lung will be presented at the 15th Annual Connective Tissue Oncology Society (CTOS) Meeting being held in Miami Beach, Florida on November 6th, 2009.
No Comments »
Filed under: Pharmacy News
Eisai Inc. today announced preliminary results from a recently completed Phase III study with eribulin mesylate (E7389), discovered and developed by the company, in patients with locally advanced or metastatic breast cancer.
No Comments »
Filed under: Pharmacy News
AcelRx Pharmaceuticals, Inc. today announced that it has successfully completed an End-of-Phase 2 meeting with the FDA for ARX-01, a drug/device combination product based on the company’s proprietary NanoTab(TM) dosage form, which enables delivery of sufentanil by the non-invasive oral transmucosal (sublingual) route.
No Comments »
Filed under: Pharmacy News
